AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2023
Mar 17, 2023
33510_dirs_2023-03-17_3920eb4d-10bb-437f-953d-4c962f003d56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Perspective Therapeutics, Inc. (ISR)
CIK: 0000728387
Period of Report: 2023-02-03
Reporting Person: Williamson Robert F III (Director)
More from Perspective Therapeutics, Inc.
Report Publication Announcement
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Report Publication Announcement
2026
May 11
Report Publication Announcement
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16